Optimization of novel tocopheryl acetate nanoemulsions for parenteral delivery of curcumin for therapeutic intervention of sepsis

Expert Opinion on Drug Delivery

Volumn 11, Issue 11, 2014, Pages 1697-1712

  Shukla, Prashant ^a   Dwivedi, Pankaj ^a   Gupta, Pramod Kumar ^a   Mishra, Prabhat Ranjan ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Carbonyl protein; Cytokines; Lipid peroxides; Lipopolysaccharide; Lung edema; Myeloperoxidase; Sepsis

Indexed keywords

ALPHA TOCOPHEROL; CURCUMIN; LIPID PEROXIDE; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ANTIBODY; CYTOKINE; DRUG CARRIER; EMULSION; NANOPARTICLE; NONSTEROID ANTIINFLAMMATORY AGENT; VITAMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; HEMOLYSIS; HISTOPATHOLOGY; IN VITRO STUDY; LIGHT SCATTERING; LIVER INJURY; LUNG INJURY; MALE; NANOEMULSION; NONHUMAN; OXIDATIVE STRESS; RAT; SEPSIS; SUSTAINED DRUG RELEASE; TISSUE DISTRIBUTION; TRANSMISSION ELECTRON MICROSCOPY; ULTRASOUND; ZETA POTENTIAL; ANIMAL; BLOOD; CELL LINE; CHEMISTRY; DISEASE MODEL; EMULSION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FLOW CYTOMETRY; INFUSION; LIVER DISEASES; METABOLISM; MICROBIOLOGY; PULMONARY EDEMA; SPRAGUE DAWLEY RAT;

ALPHA-TOCOPHEROL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; CURCUMIN; CYTOKINES; DISEASE MODELS, ANIMAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EMULSIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FLOW CYTOMETRY; INFUSIONS, PARENTERAL; LIPID PEROXIDES; LIPOPOLYSACCHARIDES; LIVER DISEASES; MALE; NANOPARTICLES; PULMONARY EDEMA; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; TISSUE DISTRIBUTION; VITAMINS;

EID: 84911481203     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2014.932769     Document Type: Article

References (60)

1. Namas R, Zamora R, Namas R, et al. Sepsis: something old, something new, and a systems view. J Crit Care 2012;27(3):314. e1-11 .
2. Mishra PR. An investigation on the approach to target lipopolysaccharide through polymeric capped nanostructured formulation for the management of sepsis. J Biomed Nanotechnol 2011;7(1):47-9
3. Yilmaz Savcun G, Ozkan E, Dulundu E, et al. Antioxidant and anti-inflammatory effects of curcumin against hepatorenal oxidative injury in an experimental sepsis model in rats. Ulus Travma Acil Cerrahi Derg 2013;19(6):507-15
4. Xu F, Lin SH, Yang YZ, et al. The effect of curcumin on sepsis-induced acute lung injury in a rat model through the inhibition of the TGF-beta1/SMAD3 pathway. Int Immunopharmacol 2013;16(1):1-6
5. Siddiqui AM, Cui X, Wu R, et al. The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma. Crit Care Med 2006;34(7):1874-82
6. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol 2008;75(4):787-809
7. Zou P, Helson L, Maitra A, et al. Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated rats. Mol Pharm 2013;10(5):1977-87
8. Ariga K, Yamauchi Y, Rydzek G, et al. Layer-by-layer nanoarchitectonics: invention, innovation, and evolution. Chem Lett 2014;43(1):36-68
9. Shukla P, Gupta G, Singodia D, et al. Emerging trend in nano-engineered polyelectrolyte-based surrogate carriers for delivery of bioactives. Expert Opin Drug Deliv 2010;7(9):993-1011
10. Lee M-H, Lin H-Y, Chen H-C, Thomas JL. Ultrasound mediates the release of curcumin from microemulsions. Langmuir 2008;24(5):1707-13
11. Ariga K, Kawakami K, Hill JP. Emerging pressure-release materials for drug delivery. Expert Opin Drug Deliv 2013;10(11):1465-9
12. Ren X, Svirskis D, Alany RG, et al. In-situ phase transition from microemulsion to liquid crystal with the potential of prolonged parenteral drug delivery. Int J Pharm 2012;431(1-2):130-7
13. Constantinides PP, Tustian A, Kessler DR. Tocol emulsions for drug solubilization and parenteral delivery. Adv Drug Deliv Rev 2004;56(9):1243-55.
14. Konukoglu D, Iynem H, Ziylan E. Antioxidant status in experimental peritonitis: effects of alpha tocopherol and taurolin. Pharmacol Res 1999;39(3):247-51
15. Ma Z, Haddadi A, Molavi O, et al. Micelles of poly(ethylene oxide)-b-poly (epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. J Biomed Mater Res A 2008;86A(2):300-10
16. Goyal A, Shukla P, Srivastava A. Factors influencing drug release characteristic from hydrophilic polymer matrix tablet. Asian J Pharm Clin Res 2009;2(1):93-7
17. Jain V, Shukla P, Pal R, Mishra PR. Cationic nanoemulsions bearing ciprofloxacin surf-plexes enhances its therapeutic efficacy in conditions of e. coli induced peritonitis and sepsis. Pharm Res 2014;1-13doi:10.1007/s11095-014-1360-0
18. Yang J, Li W, Duan M, et al. Large dose ketamine inhibits lipopolysaccharideinduced acute lung injury in rats. Inflamm Res 2005;54(3):133-7
19. Merza M, Wetterholm E, Zhang S, et al. Inhibition of geranylgeranyltransferase attenuates neutrophil accumulation and tissue injury in severe acute pancreatitis. J Leukoc Biol 2013;94(3):493-502
20. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemie myocardium. J Pharmacol Methods 1985;14(3):157-67
21. Zhang H, Slutsky A, Vincent J-L. Oxygen free radicals in ARDS, septic shock and organ dysfunction. Intensive Care Med 2000;26(4):474-6
22. Scheiermann P, Pischke SE. Lipid peroxidation in multidrug-resistant Gram-negative sepsis: translating science to the septic patient? Crit Care 2013;17(2):120
23. Winterbourn CC, Buss IH, Chan TP, et al. Protein carbonyl measurements show evidence of early oxidative stress in critically ill patients. Crit Care Med 2000;28(1):143-9
24. Dalle-Donne I, Rossi R, Giustarini D, et al. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 2003;329(1):23-38
25. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95(2):351-8
26. Fagan JM, Sleczka BG, Sohar I. Quantitation of oxidative damage to tissue proteins. Int J Biochem Cell Biol 1999;31(7):751-7
27. Papadopoulou V, Kosmidis K, Vlachou M, Macheras P. On the use of the Weibull function for the discernment of drug release mechanisms. Int J Pharm 2006;309(1-2):44-50
28. Gupta GK, Gupta VK, Shukla P, et al. Investigations on cellular interaction of polyelectrolyte based nano-walled reservoir using MCF-7 cell lines: a novel chemotherapeutic approach. J Pharm Pharmacol 2009;61(12):1601-7
29. Amin K, Dannenfelser RM. In vitro hemolysis: guidance for the pharmaceutical scientist. J Pharm Sci 2006;95(6):1173-6
30. Abe S, Tanaka Y, Fujise N, et al. An Antioxidative nutrient-rich enteral diet attenuates lethal activity and oxidative stress induced by lipopolysaccharide in mice. JPEN J Parenter Enteral Nutr 2007;31(3):181-7
31. Vittorini S, Paradiso C, Donati A, et al. The age-related accumulation of protein carbonyl in rat liver correlates with the age-related decline in liver proteolytic activities. J Gerontol A Biol Sci Med Sci 1999;54(8):B318-23
32. Mohamadin AM, Elberry AA, Elkablawy MA, et al. Montelukast, a leukotriene receptor antagonist abrogates lipopolysaccharide-induced toxicity and oxidative stress in rat liver. Pathophysiology 2011;18(3):235-42
33. Chang SW. Pulmonary intravascular inflammation in sepsis and liver-disease. Sem Resp Crit Care Med 1994;15(6):463-72
34. Hagiwara S, Koga H, Iwasaka H, et al. ETS-GS, a new anti-oxidative drug, protects against lipopolysaccharideinduced acute lung and liver injury. J Surg Res 2011;171(2):734-41
35. Bian Z, Guo Y, Ha B, et al. Regulation of the inflammatory response: enhancing neutrophil infiltration under chronic inflammatory conditions. J Immunol 2012;188(2):844-53
36. Wickel DJ, Cheadle WG, Mercer-Jones MA, Garrison RN. Poor outcome from peritonitis is caused by disease acuity and organ failure, not recurrent peritoneal infection. Ann Surg 1997;225(6):744-53; discussion 53-6
37. Hadjiminas DJ, McMasters KM, Peyton JC, et al. Passive immunization against tumor necrosis factor and interleukin-1 fails to reduce lung neutrophil sequestration in chronic sepsis. Shock 1994;2(5):376-80
38. Vachharajani V, WANG SW, Mishra N, et al. Curcumin modulates leukocyte and platelet adhesion in murine sepsis. Microcirculation 2010;17(6):407-16
39. Date AA, Nagarsenker MS. Parenteral microemulsions: an overview. Int J Pharm 2008;355(1-2):19-30
40. Hu L, Jia Y, Niu F, et al. Preparation and enhancement of oral bioavailability of curcumin using microemulsion vehicle. J Agric Food Chem 2012;60(29):7137-41
41. Sun D, Zhuang X, Xiang X, et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther 2010;18(9):1606-14
42. Began G, Sudharshan E, Udaya Sankar K, Appu Rao AG. Interaction of curcumin with phosphatidylcholine: a spectrofluorometric study. J Agric Food Chem 1999;47(12):4992-7
43. Sou K, Inenaga S, Takeoka S, Tsuchida E. Loading of curcumin into macrophages using lipid-based nanoparticles. Int J Pharm 2008;352(1-2):287-93
44. Chen C, Johnston TD, Jeon H, et al. An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells. Int J Pharm 2009;366(1-2):133-9
45. Kaminaga Y, Nagatsu A, Akiyama T, et al. Production of unnatural glucosides of curcumin with drastically enhanced water solubility by cell suspension cultures of Catharanthus roseus. FEBS Lett 2003;555(2):311-16
46. Macedo AS, Quelhas S, Silva AM, et al. Nanoemulsions for delivery of flavonoids: formulation and in vitro release of rutin as model drug. Pharm Dev Technol 2014;19(6):677-80
47. Rodŕguez-hornedo N, Murphy D. Significance of controlling crystallization mechanisms and kinetics in pharmaceutical systems. J Pharm Sci 1999;88(7):651-60
48. Jung KK, Lee HS, Cho JY, et al. Inhibitory effect of curcumin on nitric oxide production from lipopolysaccharide-activated primary microglia. Life Sci 2006;79(21):2022-31
49. Kang G, Kong P-J, Yuh Y-J, et al. Curcumin suppresses lipopolysaccharideinduced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor kappaB bindings in BV2 microglial cells. J Pharmacol Sci 2004;94(3):325-8
50. Pan M-H, Lin-Shiau S-Y, Lin J-K. Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages. Biochem Pharmacol 2000;60(11):1665-76
51. Gao Y, Li Z, Sun M, et al. Preparation and characterization of intravenously injectable curcumin nanosuspension. Drug Deliv 2011;18(2):131-42
52. Ding J, Wang Y, Ma M, et al. CT/fluorescence dual-modal nanoemulsion platform for investigating atherosclerotic plaques. Biomaterials 2013;34(1):209-16
53. Durant R, Klouche K, Delbosc S, et al. Superoxide anion overproduction in sepsis: effects of vitamin e and simvastatin. Shock 2004;22(1):34-9
54. Kogure K, Morita M, Hama S, et al. Enhancement by alpha-tocopheryl hemisuccinate of nitric oxide production induced by lypopolysaccharide and interferon-gamma through the upregulation of protein kinase C in rat vascular smooth muscle cells. Eur J Biochem 2002;269(9):2367-72
55. Khanduja KL, Avti PK, Kumar S, et al. Inhibitory effect of vitamin E on proinflammatory cytokines-and endotoxin-induced nitric oxide release in alveolar macrophages. Life Sci 2005;76(23):2669-80
56. Pathania V, Syal N, Pathak CM, Khanduja KL. Vitamin E suppresses the induction of reactive oxygen species release by lipopolysaccharide, interleukin-1beta and tumor necrosis factor-alpha in rat alveolar macrophages. J Nutr Sci Vitaminol (Tokyo) 1999;45(6):675-86
57. Bulger EM, Helton WS, Clinton CM, et al. Enteral vitamin E supplementation inhibits the cytokine response to endotoxin. Arch Surg 1997;132(12):1337-41
58. Ng LT, Ko HJ. Comparative effects of tocotrienol-rich fraction, alphatocopherol and alpha-tocopheryl acetate on inflammatory mediators and nuclear factor kappa B expression in mouse peritoneal macrophages. Food Chem 2012;134(2):920-5
59. Shapiro H, Lev S, Cohen J, Singer P. Polyphenols in the prevention and treatment of sepsis syndromes: rationale and pre-clinical evidence. Nutrition 2009;25(10):981-97
60. Sompamit K, Kukongviriyapan U, Nakmareong S, et al. Curcumin improves vascular function and alleviates oxidative stress in non-lethal lipopolysaccharide-induced endotoxaemia in mice. Eur J Pharmacol 2009;616(1-3):192-9